IFPMA promotes sustainable solutions that encourage innovation and improve patients’ health around the world.
They represent research-based biopharmaceutical companies, and regional and national associations across the world
They engage with health and research players to facilitate the co-creation of sustainable policies and initiatives that encourage the discovery of and access to medicines and vaccines to patients globally.
In collaboration with global health community, we promote policies that foster innovation, resilient regulatory systems and high standards of quality, uphold ethical practices, and advocate sustainable health policies to meet patient and health system needs.
They are the unique, informed, and credible voice in conversation with the health community globally to find health solutions for current and future generations.